Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2022-01-06 Regulatory Filings
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
RMD to Report Second Quarter Fiscal 2022 Results 1
Regulatory Filings Classification · 90% confidence The document is a press release announcing the date and details of an upcoming earnings report for the second quarter of fiscal 2022. It provides information about the webcast and replay but does not contain any actual financial results or substantive financial data. The document is short (2163 characters) and serves as an announcement rather than the earnings release itself. Therefore, it should be classified as an Earnings Release (ER) announcement, but since it does not contain the earnings data, it is best classified as a Regulatory Filing (RNS) as a fallback for announcements that do not fit other categories.
2022-01-06 English
Statement of CDIs on issue - RMD 4 pages 23.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for December 2021, changes in securities, and reasons for changes such as transfers and new shares issued under employee plans. The document is a regulatory announcement about the company's securities issued and changes in share capital, but it does not contain financial statements, management discussion, or audit information. It is not a full financial report or earnings release. The document length is 3084 characters, which is relatively short and focused on share capital details. This fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2022-01-06 English
Statement of CDIs on issue - RMD 4 pages 23.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for November 2021, net differences in securities, and reasons for changes such as transfers and new shares issued under employee plans. The content focuses on the capital structure and securities issued rather than financial performance, management changes, or regulatory announcements. The document length is about 3093 characters, which is relatively short but contains substantive data on securities issued. This fits the definition of a Share Issue/Capital Change announcement, which covers new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2021-12-02 English
FORM 8-K Annual Meeting Stockholders 3 pages 35.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 18, 2021, by ResMed Inc. The key content is under Item 5.07, which reports the submission of matters to a vote of security holders at the annual meeting. It details the election of directors, ratification of the independent auditor, and advisory approval of executive compensation. This corresponds to an official announcement of voting results from a shareholder meeting. The document length is 4089 characters, which is relatively short and focused on voting results rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-11-21 English
Update - Dividend/Distribution - RMD 4 pages 26.4KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about dividend payment amounts, record dates, ex-dates, payment dates, currency, withholding tax rates, and updates to previous dividend announcements. It specifically discusses dividend details for ResMed Inc., including foreign exchange rates and tax treaty implications. The content is focused on dividend declaration and payment information rather than financial results, management commentary, or regulatory certifications. The document length is over 6,000 characters and contains substantive dividend details, fitting the definition of a Notice of Dividend Amount (DIV).
2021-11-11 English
Statement of CDIs on issue - RMD 4 pages 23.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and contains detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for October 2021, net differences in securities, and reasons for changes such as transfers and new shares issued under employee plans. The content focuses on securities issued and changes in share capital rather than financial performance, management discussion, or regulatory certifications. The document length is 3093 characters, which is relatively short but contains substantive data on securities issued. This matches the description of a Share Issue/Capital Change announcement, which covers new share issues and capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2021-11-04 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.